An Institute of Medicine report said coordination by the U.S. government, academia and private industry is needed if new biological tests to detect disease at an early and curable stage are to be developed. A lack of uniform standards and unclear regulatory authority have hindered the development of biomarkers, the report said.

Full Story:
Red Herring

Related Summaries